WALTER THOMAS: Open Payments
NPI 1952379463 · SIMI VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,344 in 43 payments from 9 companies in 2025. Trend: 2023 $975 · 2024 $1,061 · 2025 $1,344
Food & beverage: $1,344
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $532 |
| Saxum Surgical, Inc. | 1 | $203 |
| Indivior Inc. | 7 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $164 |
| Vanda Pharmaceuticals Inc. | 3 | $100 |
| Alkermes, Inc. | 2 | $60 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Amgen Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
Products named: VRAYLAR, SUBLOCADE, CAPLYTA, QULIPTA, FANAPT, UBRELVY, Auvelity, VIVITROL.
Industry payments across CA — which companies pay providers there.
